Wealthstreet Investment Advisors LLC bought a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,043 shares of the pharmacy operator’s stock, valued at approximately $947,000.

Several other hedge funds have also recently made changes to their positions in the company. Hudock Capital Group LLC grew its position in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Westside Investment Management Inc. grew its position in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 125 shares during the period. Zions Bancorporation grew its position in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,239 shares during the period. IHT Wealth Management LLC grew its position in Walgreens Boots Alliance by 46.3% during the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 2,199 shares during the period. Finally, Bristlecone Advisors LLC bought a new position in Walgreens Boots Alliance during the third quarter valued at about $135,000. Institutional investors own 61.57% of the company’s stock.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $68.49 on Thursday. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The firm has a market cap of $67,850.00, a PE ratio of 18.92, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business earned $1.10 earnings per share. sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.34%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.

Walgreens Boots Alliance declared that its Board of Directors has authorized a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Several equities analysts recently weighed in on WBA shares. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research report on Wednesday, December 27th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Robert W. Baird restated an “outperform” rating and set a $80.00 price target (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup reduced their price target on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday, November 2nd. Ten analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $85.05.

In other Walgreens Boots Alliance news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The stock was purchased at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.80% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: “13,043 Shares in Walgreens Boots Alliance Inc (WBA) Acquired by Wealthstreet Investment Advisors LLC” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/15/13043-shares-in-walgreens-boots-alliance-inc-wba-acquired-by-wealthstreet-investment-advisors-llc.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.